ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

STOK Stoke Therapeutics Inc

14,13
1,33 (10,39%)
15 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Stoke Therapeutics Inc STOK NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
1,33 10,39% 14,13 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
13,25 13,17 14,80 14,13 12,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/05/202408:00BWStoke Therapeutics Reports First Quarter Financial Results..
29/04/202409:00BWStoke Therapeutics Appoints Thomas Leggett as Chief..
17/04/202409:00BWStoke Therapeutics Appoints Jason Hoitt as Chief Commercial..
04/04/202417:30BWStoke Therapeutics to Present at the 23rd Annual Needham..
28/03/202400:40BWStoke Therapeutics Announces Pricing of Upsized $125 Million..
26/03/202417:07BWStoke Therapeutics Announces Proposed Public Offering
25/03/202417:01BWStoke Therapeutics Reports Fourth Quarter and Full Year 2023..
17/01/202418:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
08/01/202410:00BWStoke Therapeutics Highlights Strategic Priorities and..
04/01/202418:30BWStoke Therapeutics to Present at the 42nd Annual J.P. Morgan..
01/12/202311:00BWStoke Therapeutics Presents Data From Multiple Studies of..
21/11/202310:00BWStoke Therapeutics to Present Data from the Company’s Dravet..
07/11/202309:00BWStoke Therapeutics Reports Third Quarter Financial Results..
17/10/202317:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..
21/09/202309:00BWStoke Therapeutics to Participate in the 2023 Cantor Global..
20/09/202317:30BWStoke Therapeutics Appoints Ian Smith to its Board of..
05/09/202308:00BWStoke Therapeutics Presents Data Related to the Ongoing..
07/08/202308:00BWStoke Therapeutics Reports Second Quarter Financial Results..
02/08/202309:00BWStoke Therapeutics to Present at the Canaccord Genuity 43rd..
25/07/202308:00BWStoke Therapeutics Announces Positive New Safety & Efficacy..
21/07/202308:30BWStoke Therapeutics to Host Webinar to Present New Data from..
16/06/202317:30BWStoke Therapeutics Announces Inducement Grants Under Nasdaq..